What’s Next for Teva Pharmaceutical (TEVA) Stock?

 

Teva Pharmaceutical Industries Ltd (TEVA) stock has fallen -63.04% over the last 12 months, and the average rating from Wall Street analysts is a Hold. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives TEVA stock a score of 37 out of a possible 100.

That score is mainly influenced by a long-term technical score of 3. TEVA’s score also includes a short-term technical score of 8. The fundamental score for TEVA is 99. In addition to the average rating from Wall Street analysts, TEVA stock has a mean target price of $18.26. This means analysts expect the stock to add 113.07% over the next 12 months.

Click Here to get the full Stock Score Report on Teva Pharmaceutical Industries Ltd (TEVA).

What’s Happening with TEVA Stock Today

Teva Pharmaceutical Industries Ltd (TEVA) stock has fallen -5.62% while the S&P 500 has fallen -0.17% as of 11:55 AM on Wednesday, Jun 12. TEVA has fallen -$0.51 from the previous closing price of $9.08 on volume of 17,599,268 shares. Over the past year the S&P 500 is up 3.55% while TEVA has fallen -63.04%. TEVA lost -$3.46 per share in the over the last 12 months.

Symbols: TEVA

You May Also Like